特应性皮炎
医学
哈卡特
炎症
地塞米松
免疫学
药理学
肿瘤坏死因子α
免疫球蛋白E
细胞粘附分子
促炎细胞因子
细胞因子
内科学
抗体
生物
体外
生物化学
作者
Ji-Hyun Lee,Eun Hee Jo,Bori Lee,Hyeon Min Noh,Sung-Gu Park,Young Mi Lee,Dae-Ki Kim,Min Chel Park
标识
DOI:10.3389/fphar.2019.00742
摘要
(SST) is a well-known traditional herbal medicine used for the treatment of many diseases. The aims of this study are to investigate the effects of SST on atopic dermatitis (AD) symptoms and to examine its mechanism. Human keratinocyte (HaCaT) cells were stimulated with tumor necrosis factor alpha (TNF-α)/IFN-γ to induce AD-like keratinocyte environment. 2,4-Dinitrochlorobenzene (DNCB) was used to induce AD-like skin lesions in the dorsal skin of BALB/c mice. SST and dexamethasone were administered orally for 14 day. As a result, SST treatment increased the expression of heme oxygenase-1 (HO-1), an anti-oxidative factor, and the nuclear translocation of NF-E2 p45-related factor 2 (Nrf2). In addition, the treatment also decreased the expression level of inflammatory mediator nuclear factor-κB (NF-κB) and the adhesion molecule intercellular adhesion molecule-1 (ICAM-1). SST treatment (75 and 150 mg/kg) significantly relieved AD symptoms in DNCB-induced AD-like mice by restoring skin thickness, spleen weight, immunoglobulin E (IgE), interleukin 4 (IL-4), pro-inflammatory cytokine expression, and expression of several other mediators. We found that SST alleviates AD-like skin lesions and skin inflammation by modulating various atopic symptoms and inflammatory mediators. Therefore, SST can be used as an alternative drug for the treatment of AD.
科研通智能强力驱动
Strongly Powered by AbleSci AI